Metaphase is selected because chromosome visibility is central to the analysis. Cells are arrested at this stage, when chromosomes are highly condensed rather than less readily distinguished. That concentration of chromosome material allows analysts to examine individual chromosomes and compare their relative number, size, shape, and structural appearance in an organized preparation.
Staining produces characteristic banding patterns along the condensed chromosomes. Analysts use these visible patterns together with chromosome size and shape to recognize corresponding chromosomes and assess whether a chromosome contains a large deletion, duplication, or translocation. The bands therefore add structural landmarks, rather than serving merely to make the chromosome image easier to see.
After imaging, chromosomes are digitally arranged into homologous pairs. This pairing creates a comparative framework for checking whether each expected chromosome is represented and whether corresponding chromosomes show similar structural features. Consequently, the arrangement can expose both numerical changes, such as an extra or missing chromosome, and larger structural differences between homologs.
A change in chromosome number concerns how many copies are present, whereas a structural change concerns the organization of chromosome material. Large deletions and duplications alter chromosome content, while translocations alter how segments are arranged. Separating these categories helps describe the type of abnormality observed rather than reporting only that the karyotype is unusual.
The workflow moves from cell preparation to visual interpretation. Cells are first arrested in metaphase, when chromosomes are condensed. The chromosomes are then stained to produce characteristic bands, photographed, and arranged digitally into homologous pairs. Analysts inspect the resulting arrangement for changes in chromosome number, size, shape, or large-scale structure.
Karyotype analysis is useful when the biological question concerns chromosome organization or inheritance. In clinical and biological settings, it supports evaluation of chromosomal disorders, infertility, developmental conditions, and prenatal screening. It is also applied to cancer investigations, where chromosome changes can be examined as part of the disease context.
Beyond diagnostic use, the arranged chromosome set gives biology a visible framework for studying genome organization and inheritance. Comparing chromosome number, dimensions, banding patterns, and structural relationships connects chromosome architecture with observed genetic conditions. The same cytogenetic perspective also helps investigate how chromosome changes appear in cancer, extending the method to research contexts.